FDA 510(k) FDA unclassified Substantially Equivalent 🇺🇸 United States

ARK Methotrexate II Assay

K Number: K232017 · Decision Dec 20, 2023
Classifications
1
FEI Numbers
4
Registration Numbers
4
Same Product Code
9
Applicant Total
17
Review Days
166

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ARK Methotrexate II Assay
K Number
K232017
Device Class
FDA unclassified
Clearance Type
Traditional
Medical Specialty
Unknown
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Ark Diagnostics, Inc.
Date Received
July 7, 2023
Decision Date
December 20, 2023
Product Code
LAO
Advisory Committee
Unknown
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LAO Enzyme Immunoassay, Methotrexate

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LAO), ordered by most recent decision date.

View all

Other Clearances by Ark Diagnostics, Inc.

K Number Device Name
K232522 ARK Levetiracetam II Assay
K231752 ARK Hydrocodone Assay
K201089 ARK Lacosamide Assay
K200197 ARK Fentanyl II Assay
K182280 ARK Tramadol Assay
K182779 ARK EDDP Assay
K180427 ARK Fentanyl Assay
K163359 ARK Methotrexate Assay
DEN160033 ARK Voriconazole II Assay Test System
K153596 ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control
Search all 17 clearances from Ark Diagnostics, Inc. →